FINNENCE ▪ THE WIRE FILE
THE WIRE · № 56081
News▲ Bullish
Lilly's triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes
KINDNews
DIRECTION▲ Bullish
SOURCES1
ENTITIES2
STORY SIZESTANDALONE
FIRST SEEN2026-09-29 22:00 UTC
LAST UPDATE2026-09-29 22:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Strong retatrutide weight-loss and A1C data strengthen Lilly's obesity franchise pipeline versus rivals.
Lilly obesity pipeline reinforced by trial data
CATALYST TO WATCH
Regulatory filing and further TRIUMPH readouts
MAIN RISK
Safety or tolerability issues emerge later
FULL DISPATCH
In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6 lbs (20.8%) over 80 weeks, with more than half no longer meeting the BMI criteria for obesity Participants with a baseline BMI of 35 or higher who took retatrutide 12 mg lost up to...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDEli Lilly · LLY
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
New study reveals major impact of climate change on skin health worldwide2026-09-29 22:01 UTC
New study reveals major impact of climate change on skin health worldwide2026-09-29 22:01 UTC
→CORRELATIONshares Healthcare
Essentia Health and HealthPartners CEOs discuss merger between companies2026-09-29 22:13 UTC
Essentia Health and HealthPartners CEOs discuss merger between companies2026-09-29 22:13 UTC
→CORRELATIONshares Healthcare
Wake County leaders tout growth, defend WakeMed-Atrium merger2026-09-29 22:18 UTC
Wake County leaders tout growth, defend WakeMed-Atrium merger2026-09-29 22:18 UTC
→CORRELATIONshares Healthcare
MN Attorney General promises public meetings on hospital merger and explains process2026-09-29 21:24 UTC
MN Attorney General promises public meetings on hospital merger and explains process2026-09-29 21:24 UTC
→CORRELATIONshares Healthcare
Minnesota Nurses Association raising 'serious concerns' over Essentia merger with HealthPartners2026-09-29 22:12 UTC
Minnesota Nurses Association raising 'serious concerns' over Essentia merger with HealthPartners2026-09-29 22:12 UTC
→CORRELATIONshares Healthcare
Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder2026-09-29 22:45 UTC
Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder2026-09-29 22:45 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.